News & Analysis on Clinical Trial Services & Contract Research And Development
A new easy-to-use laser microdissection system from Olympus is set to shake up the isolation technology market by reducing sample handling and contamination when isolating cells for downstream analysis and making the process routine.
Biotechnology firm Nastech has chosen Procter & Gamble to develop and commercialise its osteoporosis nasal spray worldwide, in a lucrative deal that could reach $577m (€480m) over the life of the project and give both companies the upper hand over...
According to a new report, the market for needle-free injection devices and safety syringes will exceed $2.49bn (€2.1bn) by 2009, buoyed on by the increase of incidences in needlestick injuries and high consumer demand for syringe alternatives.
US pharmaceuticals and skin care specialist SkinMedica has developed a timed release delivery system for the active ingredients of an acne treatment that is said to up efficacy and lower the chances of skin irritation.
New data that shows the effectiveness of TTP LabTech's Acumen Explorer for high content screening at high throughput reveals the advances high content screening has made in applications such as protein kinase activation, cell cycle analysis and...
British biotechnology firm Angel has won a manufacturing contract from stem cell therapeutics expert ReNeuron Group to produce a master cell bank for Huntington's disease, as the company's demand for stem cells increases.